{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:39:26Z","timestamp":1775187566175,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Canadian Institutes of Health Research Mitacs Praxis ICORD"},{"name":"Mitacs ICORD Praxis CIHR"},{"name":"Canadian Institutes of Health Research Michael Smith Foundation for Health Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Aging Mech Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pressure injuries (PIs), also known as bedsores or pressure ulcers, are a major cause of death and morbidity in the elderly. The serine protease, Granzyme B (GzmB), contributes to skin aging and impaired wound healing. Aging is a major risk factor for PIs; thus, the role of GzmB in PI pathogenesis was investigated. GzmB levels in human PI tissue and wound fluids were markedly elevated. A causative role for GzmB was assessed in GzmB knockout (GzmB\u2212\/\u2212) and wild-type (WT) mice using a murine model of PI. An apolipoprotein E knockout (ApoE\u2212\/\u2212) model of aging and vascular dysfunction was also utilized to assess GzmB in a relevant age-related model better resembling tissue perfusion in the elderly. PI severity displayed no difference between young GzmB\u2212\/\u2212 and WT mice. However, in aged mice, PI severity was reduced in mice lacking GzmB. Mechanistically, GzmB increased vascular wall inflammation and impaired extracellular matrix remodeling. Together, GzmB is an important contributor to age-dependent impaired PI healing.<\/jats:p>","DOI":"10.1038\/s41514-021-00059-6","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T11:03:22Z","timestamp":1614942202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Granzyme B mediates impaired healing of pressure injuries in aged skin"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7409-4386","authenticated-orcid":false,"given":"Christopher T.","family":"Turner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Bolsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3858-5791","authenticated-orcid":false,"given":"Matthew R.","family":"Zeglinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Ponomarev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katlyn","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Hiroyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Papp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-2816","authenticated-orcid":false,"given":"David J.","family":"Granville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"59_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mvr.2015.04.004","volume":"100","author":"I Bentov","year":"2015","unstructured":"Bentov, I. & Reed, M. J. The effect of aging on the cutaneous microvasculature. Microvasc. Res. 100, 25\u201331 (2015).","journal-title":"Microvasc. Res."},{"key":"59_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-018-0997-7","volume":"18","author":"E Jaul","year":"2018","unstructured":"Jaul, E., Barron, J., Rosenzweig, J. P. & Menczel, J. An overview of co-morbidities and the development of pressure ulcers among older adults. BMC Geriatr.18, 305 (2018).","journal-title":"BMC Geriatr."},{"key":"59_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bmjqs.2010.043125","volume":"20","author":"K Vanderwee","year":"2011","unstructured":"Vanderwee, K. et al. Assessing the adequacy of pressure ulcer prevention in hospitals: a nationwide prevalence survey. BMJ Qual. Saf. 20, 260\u2013267 (2011).","journal-title":"BMJ Qual. Saf."},{"key":"59_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/0092-8674(87)90544-7","volume":"49","author":"D Masson","year":"1987","unstructured":"Masson, D. & Tschopp, J. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 49, 679\u2013685 (1987).","journal-title":"Cell"},{"key":"59_CR5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/eji.1830250432","volume":"25","author":"S Isaaz","year":"1995","unstructured":"Isaaz, S., Baetz, K., Olsen, K., Podack, E. & Griffiths, G. M. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25, 1071\u20131079 (1995).","journal-title":"Eur. J. Immunol."},{"key":"59_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.matbio.2017.12.005","volume":"75-76","author":"CT Turner","year":"2019","unstructured":"Turner, C. T., Lim, D. & Granville, D. J. Granzyme B in skin inflammation and disease. Matrix Biol. 75-76, 126\u2013140 (2019).","journal-title":"Matrix Biol."},{"key":"59_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/acel.12298","volume":"14","author":"LG Parkinson","year":"2015","unstructured":"Parkinson, L. G. et al. Granzyme B mediates both direct and indirect cleavage of extracellular matrix in skin after chronic low-dose ultraviolet light irradiation. Aging Cell 14, 67\u201377 (2015).","journal-title":"Aging Cell"},{"key":"59_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.exger.2011.02.004","volume":"46","author":"PR Hiebert","year":"2011","unstructured":"Hiebert, P. R. et al. Granzyme B contributes to extracellular matrix remodeling and skin aging in apolipoprotein E knockout mice. Exp. Gerontol. 46, 489\u2013499 (2011).","journal-title":"Exp. Gerontol."},{"key":"59_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.423","volume":"5","author":"I Hsu","year":"2014","unstructured":"Hsu, I. et al. Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing. Cell Death Dis. 5, e1458 (2014).","journal-title":"Cell Death Dis."},{"key":"59_CR10","doi-asserted-by":"publisher","first-page":"23549","DOI":"10.1074\/jbc.M412001200","volume":"280","author":"MS Buzza","year":"2005","unstructured":"Buzza, M. S. et al. Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J. Biol. Chem. 280, 23549\u201323558 (2005).","journal-title":"J. Biol. Chem."},{"key":"59_CR11","doi-asserted-by":"publisher","first-page":"e33163","DOI":"10.1371\/journal.pone.0033163","volume":"7","author":"WA Boivin","year":"2012","unstructured":"Boivin, W. A. et al. Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-beta1. PLoS ONE 7, e33163 (2012).","journal-title":"PLoS ONE"},{"key":"59_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.88","volume":"2","author":"LS Ang","year":"2011","unstructured":"Ang, L. S. et al. Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm. Cell Death Dis. 2, e209 (2011).","journal-title":"Cell Death Dis."},{"key":"59_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajpath.2015.09.010","volume":"186","author":"Y Shen","year":"2016","unstructured":"Shen, Y. et al. Granzyme B deficiency protects against angiotensin II-induced cardiac fibrosis. Am. J. Pathol. 186, 87\u2013100 (2016).","journal-title":"Am. J. Pathol."},{"key":"59_CR14","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.vaccine.2012.01.015","volume":"30","author":"JE McElhaney","year":"2012","unstructured":"McElhaney, J. E. et al. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30, 2060\u20132067 (2012).","journal-title":"Vaccine"},{"key":"59_CR15","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/cdd.2013.96","volume":"20","author":"PR Hiebert","year":"2013","unstructured":"Hiebert, P. R., Wu, D. & Granville, D. J. Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice. Cell Death Differ. 20, 1404\u20131414 (2013).","journal-title":"Cell Death Differ."},{"key":"59_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0014-5793(04)00187-5","volume":"562","author":"FC Kurschus","year":"2004","unstructured":"Kurschus, F. C. et al. Killing of target cells by redirected granzyme B in the absence of perforin. FEBS Lett. 562, 87\u201392 (2004).","journal-title":"FEBS Lett."},{"key":"59_CR17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","volume":"101","author":"ME Belloy","year":"2019","unstructured":"Belloy, M. E., Napolioni, V. & Greicius, M. D. A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward. Neuron 101, 820\u2013838 (2019).","journal-title":"Neuron"},{"key":"59_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jvn.2013.07.002","volume":"32","author":"AL Corniello","year":"2014","unstructured":"Corniello, A. L. et al. Predictors of pressure ulcer development in patients with vascular disease. J. Vasc. Nurs. 32, 55\u201362 (2014).","journal-title":"J. Vasc. Nurs."},{"key":"59_CR19","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1161\/01.ATV.19.11.2762","volume":"19","author":"R Yang","year":"1999","unstructured":"Yang, R. et al. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 19, 2762\u20132768 (1999).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"59_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.semvascsurg.2009.01.005","volume":"22","author":"F Beyersdorf","year":"2009","unstructured":"Beyersdorf, F. & Schlensak, C. Controlled reperfusion after acute and persistent limb ischemia. Semin. Vasc. Surg. 22, 52\u201357 (2009).","journal-title":"Semin. Vasc. Surg."},{"key":"59_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/08941930490472046","volume":"17","author":"I Stadler","year":"2004","unstructured":"Stadler, I., Zhang, R. Y., Oskoui, P., Whittaker, M. S. & Lanzafame, R. J. Development of a simple, noninvasive, clinically relevant model of pressure ulcers in the mouse. J. Invest. Surg. 17, 221\u2013227 (2004).","journal-title":"J. Invest. Surg."},{"key":"59_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4161\/viru.24530","volume":"4","author":"AV Page","year":"2013","unstructured":"Page, A. V. & Liles, W. C. Biomarkers of endothelial activation\/dysfunction in infectious diseases. Virulence 4, 507\u2013516 (2013).","journal-title":"Virulence"},{"key":"59_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2005.04.007","volume":"31","author":"AM Witkowska","year":"2005","unstructured":"Witkowska, A. M. Soluble ICAM-1: a marker of vascular inflammation and lifestyle. Cytokine 31, 127\u2013134 (2005).","journal-title":"Cytokine"},{"key":"59_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/02688697.2018.1518515","volume":"32","author":"BN Wu","year":"2018","unstructured":"Wu, B. N. et al. High serum sICAM-1 is correlated with cerebral microbleeds and hemorrhagic transformation in ischemic stroke patients. Br. J. Neurosurg. 32, 631\u2013636 (2018).","journal-title":"Br. J. Neurosurg."},{"key":"59_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.RES.0000026420.22406.79","volume":"91","author":"ES Wijelath","year":"2002","unstructured":"Wijelath, E. S. et al. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ. Res. 91, 25\u201331 (2002).","journal-title":"Circ. Res."},{"key":"59_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/01.RES.0000246849.17887.66","volume":"99","author":"ES Wijelath","year":"2006","unstructured":"Wijelath, E. S. et al. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor\/matrix protein synergism. Circ. Res. 99, 853\u2013860 (2006).","journal-title":"Circ. Res."},{"key":"59_CR27","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.4049\/jimmunol.151.12.7161","volume":"151","author":"CJ Froelich","year":"1993","unstructured":"Froelich, C. J. et al. Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. J. Immunol. 151, 7161\u20137171 (1993).","journal-title":"J. Immunol."},{"key":"59_CR28","doi-asserted-by":"publisher","first-page":"8157","DOI":"10.1074\/jbc.M607436200","volume":"282","author":"H Hernandez-Pigeon","year":"2007","unstructured":"Hernandez-Pigeon, H. et al. UVA induces granzyme B in human keratinocytes through MIF: implication in extracellular matrix remodeling. J. Biol. Chem. 282, 8157\u20138164 (2007).","journal-title":"J. Biol. Chem."},{"key":"59_CR29","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/bjd.17268","volume":"180","author":"SM Pilkington","year":"2019","unstructured":"Pilkington, S. M., Barron, M. J., Watson, R. E. B., Griffiths, C. E. M. & Bulfone-Paus, S. Aged human skin accumulates mast cells with altered functionality that localize to macrophages and vasoactive intestinal peptide-positive nerve fibres. Br. J. Dermatol. 180, 849\u2013858 (2019).","journal-title":"Br. J. Dermatol."},{"key":"59_CR30","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/sj.cdd.4402183","volume":"14","author":"J Pardo","year":"2007","unstructured":"Pardo, J. et al. Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin. Cell Death Differ. 14, 1768\u20131779 (2007).","journal-title":"Cell Death Differ."},{"key":"59_CR31","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.4049\/jimmunol.1402316","volume":"194","author":"S Elavazhagan","year":"2015","unstructured":"Elavazhagan, S. et al. Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity. J. Immunol. 194, 2786\u20132795 (2015).","journal-title":"J. Immunol."},{"key":"59_CR32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/labinvest.2014.62","volume":"94","author":"A Hendel","year":"2014","unstructured":"Hendel, A., Hsu, I. & Granville, D. J. Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability. Lab. Invest. 94, 716\u2013725 (2014).","journal-title":"Lab. Invest."},{"key":"59_CR33","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1136\/jcp.2003.015495","volume":"57","author":"H Miyazaki","year":"2004","unstructured":"Miyazaki, H. et al. The perforin mediated apoptotic pathway in lung injury and fibrosis. J. Clin. Pathol. 57, 1292\u20131298 (2004).","journal-title":"J. Clin. Pathol."},{"key":"59_CR34","doi-asserted-by":"publisher","first-page":"21671","DOI":"10.1073\/pnas.1016233107","volume":"107","author":"TA Jarvinen","year":"2010","unstructured":"Jarvinen, T. A. & Ruoslahti, E. Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice. Proc. Natl Acad. Sci. USA 107, 21671\u201321676 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fphar.2017.00461","volume":"8","author":"KL Walton","year":"2017","unstructured":"Walton, K. L., Johnson, K. E. & Harrison, C. A. Targeting TGF-beta mediated SMAD signaling for the prevention of fibrosis. Front. Pharmacol. 8, 461 (2017).","journal-title":"Front. Pharmacol."},{"key":"59_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00000658-196502000-00019","volume":"161","author":"SM Levenson","year":"1965","unstructured":"Levenson, S. M. et al. The healing of rat skin wounds. Ann. Surg. 161, 293\u2013308 (1965).","journal-title":"Ann. Surg."}],"container-title":["npj Aging and Mechanisms of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41514-021-00059-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-021-00059-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-021-00059-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T12:29:15Z","timestamp":1697977755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41514-021-00059-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1038\/s41514-021-00059-6","relation":{},"ISSN":["2056-3973"],"issn-type":[{"value":"2056-3973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"4 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.J.G. is co-Founder and Chief Scientific Officer of viDA Therapeutics. Other authors state no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}